Livzon Pharmaceutical Group Inc. Stock
Stocks
000513
CNE0000002Y8
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.87 CNY | +1.56% |
|
+3.95% | -7.52% |
| Jun. 01 | Livzon Pharma Unit Wins China Approval for Fertility Drug Biosimilar | MT |
| Jun. 01 | Livzon Pharmaceutical Drug Accepted for China Review | MT |
| Market Cap | 25.79B 3.81B 3.29B 3.03B 2.84B 5.32B 362B 5.4B 35.82B 13.96B 176B 14.3B 14B 611B | P/E Ratio 2026 * |
13.9x | P/E Ratio 2027 * | 12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 18.26B 2.7B 2.33B 2.15B 2.01B 3.77B 257B 3.83B 25.36B 9.89B 125B 10.13B 9.91B 432B | EV / Sales 2026 * |
1.54x | EV / Sales 2027 * | 1.53x |
| Free-Float |
36.41% | Yield 2026 * |
4.49% | Yield 2027 * | 6.03% |
| 1 day | +1.56% | ||
| 1 week | +3.95% | ||
| Current month | +3.27% | ||
| 1 month | +0.19% | ||
| 3 months | -8.23% | ||
| 6 months | -9.28% | ||
| Current year | -7.52% |
| 1 week | 29.71 |  | 31.92 |
| 1 month | 29.71 | | 31.92 |
| Current year | 29.71 | | 37.42 |
| 1 year | 29.71 | | 44.87 |
| 3 years | 29.71 | | 44.87 |
| 5 years | 28.88 | | 52.36 |
| 10 years | 17.95 | | 62.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sheng Wang
DFI | Director of Finance/CFO | 54 | 2025-08-31 |
Da Ping Liu
PSD | President | 38 | 2026-02-27 |
De Long Ye
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Bao Guo Zhu
CHM | Chairman | 64 | 2001-12-31 |
Qing Feng Qiu
BRD | Director/Board Member | 55 | 2007-03-31 |
Yang Gang Tang
BRD | Director/Board Member | 57 | 2019-02-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-05-05 | Other | Director | 112,000 | 0.0365% | ||
| 24-05-12 | Other | Director | 48,000 | 0.0079% | ||
| 22-11-22 | Other | Director | 160,000 | 0.0264% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.56% | +3.95% | -14.33% | -17.22% | 3.81B | |
| -2.41% | +0.14% | +38.28% | +154.20% | 1,010B | |
| +1.07% | +3.48% | +53.32% | +49.85% | 580B | |
| +1.32% | +0.22% | +19.18% | +64.65% | 402B | |
| +0.77% | 0.00% | +21.28% | +16.70% | 330B | |
| +0.44% | +3.48% | +25.65% | +35.66% | 281B | |
| -0.85% | -2.86% | +22.54% | +14.67% | 280B | |
| +1.66% | +1.20% | -44.35% | -47.35% | 197B | |
| +0.32% | +1.61% | +20.32% | +60.01% | 192B | |
| -0.22% | -2.76% | +14.19% | +60.09% | 156B | |
| Average | +0.37% | +1.42% | +15.61% | +39.12% | 343.27B | |
| Weighted average by Cap. | -0.23% | +1.04% | +27.72% | +70.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11.88B 1.76B 1.52B 1.4B 1.31B 2.45B 167B 2.49B 16.5B 6.43B 81.23B 6.59B 6.45B 281B | 12.87B 1.9B 1.64B 1.51B 1.42B 2.65B 181B 2.7B 17.87B 6.97B 87.97B 7.14B 6.98B 305B |
| Net income | 2.05B 303M 261M 241M 225M 422M 28.76B 429M 2.84B 1.11B 14B 1.14B 1.11B 48.47B | 2.31B 341M 294M 271M 254M 476M 32.41B 483M 3.2B 1.25B 15.77B 1.28B 1.25B 54.62B |
| Net Debt | -7.53B -1.11B -961M -885M -829M -1.55B -106B -1.58B -10.45B -4.08B -51.47B -4.17B -4.09B -178B | -6.11B -902M -779M -718M -672M -1.26B -85.78B -1.28B -8.48B -3.31B -41.75B -3.39B -3.31B -145B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 31.87 ¥ | +1.56% | 7,738,352 |
| 26-06-11 | 31.38 ¥ | +0.42% | 5,771,881 |
| 26-06-10 | 31.25 ¥ | +2.56% | 6,779,906 |
| 26-06-09 | 30.47 ¥ | +1.97% | 4,855,337 |
| 26-06-08 | 29.88 ¥ | -2.54% | 5,470,205 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 000513 Stock
Select your edition
All financial news and data tailored to specific country editions
